Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymoglobulin and Delayed CNI for Renal Protection in Liver Transplant
NCT02544113Phase 2Completed
- Sponsor
- Cleveland Clinic
- Start
- Dec 2015
- Primary completion
- Jun 2018
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of antithymocyte globulin in acute kidney injury (AKI), sponsored by Cleveland Clinic. Started Dec 2015; status: completed.
02
Drugs
antithymocyte globulin
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT02544113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02544113.